Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance

Background The majority of adverse drug reactions (ADRs) reported in the summary of product characteristics (SPCs) are based on pivotal clinical trials, performed under controlled conditions and with selected patients. Objectives (1) to observe ADRs in the real-world setting and to evaluate if the s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Clin Pharm
Asıl Yazarlar: Fornasier, G., Taborelli, M., Francescon, S., Polesel, J., Aliberti, M., De Paoli, P., Baldo, P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2018
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6132980/
https://ncbi.nlm.nih.gov/pubmed/29785683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-018-0653-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller